Ridha Charfeddine’s Unimed still seeking Gulf partner
Africa Business+ editors reveal the details.
19/11/2021 at 16h08, by Africa Business+
During the financial communication of the pharmaceutical laboratory Unimed, on November 18, Africa Business+ learned that the company, majority-owned by Ridha Charfeddine, was in advanced discussions with two investment funds, one Emirati, the other English, to support its international development strategy, especially in the Gulf.
Recommended articles
Private Equity
22/03/2023 at 18h46, by Africa Business+
Tarek Mounib of East Lane Partners has one last LP to convince for the first round of funding
Tarek Mounib has gone solo with East Lane Partners, but he’s got to wait for his new investment vehicle...
Agri-food industry
08/06/2022 at 16h26, by Africa Business+
East Lane Partners on track for a first closing in early 2023
The Egyptian investor will dedicate tens of millions of dollars of investments to North African companies.
Private Equity
05/11/2020 at 22h39, by Africa Business+
Tarek Mounib, the potential buyer of Ridha Charfeddine’s Unimed assets
Tunisian businessman Ridha Charfeddine is planning to sell his pharmaceutical company to a new player...